Autolus Therapeutics Plc (AUTL)
1.44
+0.02
(+1.41%)
USD |
NASDAQ |
Jan 15, 16:00
1.46
+0.02
(+1.39%)
After-Hours: 20:00
Autolus Therapeutics SG&A Expense (TTM): 129.58M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | 5.354M |
| NuCana Plc | 9.964M |
| Mereo BioPharma Group Plc | 25.26M |
| Bicycle Therapeutics Plc | 80.05M |
| Adaptimmune Therapeutics Plc | 90.49M |